BioNTech SE (BNTX) Depreciation & Amortization (IS) (2021 - 2023)
BioNTech SE (BNTX) posted Depreciation & Amortization (IS) of $8.8 million for Q3 2023, up 90.11% on a QoQ basis from $4.6 million in Q3 2022, and up 90.11% year-over-year from $4.6 million in Q3 2022.
BioNTech SE (BNTX) has 3 years of Depreciation & Amortization (IS) data on file, last reported at $8.8 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 127,436.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 8.82 Mn |
| Sep 30, 2022 | 4.64 Mn |
| Sep 30, 2021 | 10.02 Mn |